Dimeric peroxiredoxins are druggable targets in human Burkitt lymphomaAnna Trzeciecka(Medical University of Warsaw), Małgorzata Firczuk(Medical University of Warsaw)OncotargetNovember 30, 201510.18632/oncotarget.6435Cited by 47SaveCiteExport RISWatch citationsRelated PapersInhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate|Redox Biology|2018|42